Cytochroma, Mitsubishi Tanabe in CTA018 deal

Cytochroma (Markham, Ontario) granted Mitsubishi Tanabe Pharma (Tokyo:4508; Osaka:4508) an exclusive license to develop and commercialize CTA018 and follow-on compounds

Read the full 202 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE